Some of the ADAMs, such as ADAM9, ADAM10, ADAM12, ADAM15, and ADAM17, are frequently upregulated in tumor tissues as well as cancer cell lines, and their expression often correlates with adverse patient survival and/or treatment response [11–17]. The gene discussed is ADAM17; the disease is cancer.